
    
      Single country, Multi-center, prospective, randomised, double-blind, 2 arms parallel-group,
      vehicle-controlled, 6 weeks, phase 2a trial in subjects with mild to moderate inverse
      psoriasis. LEO 124249 ointment 30 mg/g and LEO 124249 ointment vehicle treatments will be
      compared with regards to efficacy and safety.
    
  